The Street Might Be Discounting A Potential Blockbuster Drug From Acceleron

By: via Benzinga
Acceleron Pharma Inc (NASDAQ: XLRN) shares have plunged 23 percent since December 21. Credit Suisse’s Kennen MacKay ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.